eDoorways Corporation, a web-based consumer problem solving gateway, lifestyle information source, and online business-to-consumer marketplace, recently unveiled its “SOLVE” doorway in Austin, TX. The October 9, 2009 edition of the Austin Business Journal covered the event.

Staff Writer Christopher Calnan penned an article called “New way to link shops, customers debuts; Vying for business via instant messaging.” Christopher was in attendance at the unveiling of the “SOLVE” doorway, on which he commented, “At its most basic, ‘SOLVE’ is an online tool that enables consumers to send instant messages to several businesses at once to get them to compete with each other on prices.”

Commenting on the performance of eDoorways CEO Gary Kimmons, Calnan stated, “Gary Kimmons hit the stage in Austin last week, channeling Apple Inc. CEO Steve Jobs, to launch a new online tool developed by Kimmons’ company, eDoorways Corp. Looking like

...

U.S. stocks jumped to their highest level in almost a year after Federal Reserve’s Beige Book survey said the economy is showing signs of stabilization.  Although shares closed off their session highs, the report was enough to lift sentiments on the Street.  However, the report did indicate that labor markets are weak and retail sales are not picking up.  Industrial shares rallied after Goldman Sachs raised its view on the U.S. multi-industry group, noting the industrial activity is picking up.  Treasuries made a partial comeback after the government’s 10-year note auction witnessed a strong response.

The greenback remained near its year lows against a basket of currencies while gold prices eased a little to settle at $995.30.  Crude prices were slightly up ahead of the September OPEC meeting.

The Dow Jones industrial average, which rose as much as 80 points earlier in the session, pared some gains to close

...

Steve Jobs took the stage today as he unveiled new IPODS for Apple Inc.  Jobs recently returned to work after a six month leave of absence to recuperate from a liver transplant.  While analysts and investors speculate on Jobs’ health and his future at Apple, I simply wish to revisit my very first post as THE CROSSHAIRS TRADER wherein I focused on Jobs as an inspiration for all of us. 

If you have never heard this speech I suggest you take a few minutes to do so now; if you have, listen again as Jobs provides encouragement that is applicable to us traders and serves as an ever present  reminder about how we should take advantage of all the opportunities that may come

...

GenVec, Inc.

(Public, NASDAQ:GNVC)

StocksHaven Investments profiles a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer, and is currently undergoing Phase III trials which are expected to be completed by Q1 2010. In addition to its therapeutic product development programs, GenVec is working with collaborators to develop new applications for its technology through its vaccine development programs. The Company is developing a vaccine in animal health against foot-and-mouth disease and preventative vaccines for malaria, human immunodeficiency virus (HIV), respiratory syncytial virus, and Herpes Simplex Virus Type 2 (HSV-2). Surrounded by cash infusions through grants, mutual and institutional investors, multi-purpose products with billion dollar market potential, and an already flowing revenue stream – GenVec is one company you shouldn’t pass by.

About

Genvec

...

For Immediate Release

Chicago, IL – September 3, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc. (AAPL), Palm (PALM), Nokia (NOK), Motorola (MOT) and Research in Motion (RIMM).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Wednesday’s Analyst Blog:

Apple's New iPod

Apple Inc. (AAPL) is expected to unveil a new line up of iPod portable music players for the holiday period when it will hold a special media event in San Francisco on Sept 9. Apple declined to name the products.

It is widely believed that Apple

...

Apple Inc. (AAPL) is expected to unveil a new line up of iPod portable music players for the holiday period when it will hold a special media event in San Francisco on Sept 9. Apple declined to name the products.   It is widely believed that Apple will use the event to announce major updates to the iPod Touch, the classic iPod and the iPod Nano. The upgrades could include adding a digital camera to the devices, while the iPod Touch could also be augmented with a video camera. No updates to iPod Shuffle are expected.   Apple is also expected to provide an update to the iTunes media management software at the event. Rumor has it that Steve Jobs may appear for the first time at the event after he returned to Apple from his temporary leave of absence.   Apple’s resurgence has been driven by the ...

Apple’s stock is fast approaching its 52-week high of $177.50 set almost exactly 1-yar ago and seems within striking distance of its all-time high valuation near $200.  I wrote at the beginning of the year about Apple’s intrinsic value and recommended buying the stock when it hit $89/share amid rumors of Steve Jobs’ declining health and Apple’s inability to continue to make hit products. The stock has appreciated almost 90% since and it would seem a good time to revisit the Company’s valuation.

My method of determining whether or not a stock is trading at a “value” is to determine the market’s implied valuation. Rather than attempt to model and predict a company’s operating performance, I use the current market value to back into implied growth rates. Then, I try to make a decision as far as how realistic the market implied growth rate actually is.

...

Lessons for Apple in Mays, Madoff

by The Investment U Research Team

In many ways Steve Jobs return to Apple (Nasdaq: AAPL) was overshadowed by the demise of Billy Mays and the Bernie Madoff’s sentencing.

However, there are lessons for Apple in both of these men.

Billy Mays tragic loss should give iPhone and iPod creators pause to consider what would happen if the company did lose Steve Jobs. While Tim Cook has performed strongly by many analysts accounts, he does not bring true star leadership power that Jobs does.

Apple should start addressing this now. Even Berkshire Hathaway’s (NYSE: BRK.A) Warren Buffett has Charlie Munger, and I’m sure a host of recorded and written statements of contingency plans in the meantime.

The other lesson for Apple is from Bernie Madoff. The New York Times

...

US stocks started the holiday-shortened trading week on a positive note as energy, technology and industrial shares pulled equity markets higher.  Although stocks seesawed in early trading, a gain in oil prices buoyed sentiments on the Street and investors raced to put money in the stock market. 

The Down Jones industrial average advanced 91 points or 1.1% and the S&P 500 increased 0.9%.  NASDAQ edged up 0.3%.  Volume on the NYSE was light with only 1.07 billion shares exchanging hands and advancing issues outpacing declining stocks by a three-to-two margin.  The measure of market volatility, the CBOE Vix, retreated 2.2% to 25.35%, its lowest level since mid-September.  Treasury prices jumped, with the yield on the benchmark 10-year note declining to 3.48%.  Crude prices jumped to more than $71 per barrel on higher demand expectations and reports that Nigerian militants partly shut down an offshore oil facility.    

Trading

...

* Reports suggest Xstrata and Anglo American (NASDAQ:AAUK) are engaged in merger talks in a deal which could total about $68 billion and result in the combined firm becoming the world's number-three miner behind BHP Billiton (NYSE:BHP) and Vale (NASDAQ:VALE)

* Reuters reported 100,000 of Apple (NASDAQ:AAPL) iPhone 3Gs were sold via preorders, explaining away some of the launch's diminished excitement level. Some news reports said Steve Jobs underwent a liver transplant two months ago in Tennessee, and is still due back at month's end

* Walgreen (NYSE:WAG) is expected to report fiscal third-quarter earnings of 56 cents a share

* UBS (NYSE:UBS) upgraded Vulcan Materials (NYSE:VMC) to "buy," based upon housing and infrastructure recovery

* JP Morgan (NYSE:JPM) upgraded Verisign (NASDAQ:VRSN) to "overweight" from "neutral"

* According to a Wall Street Journal report, Amazon.com (NASDAQ:AMZN) may stop conducting businesses with some retailers in states, which would force sales tax payments on online transactions

...